Primary Site >> Esophagus Cancer

Gene >> CD44

  • 1994
  • 1995
  • 1996
  • 1998
  • 1999
  • 2001
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2018
Ref: [Metastasis-related genes].
PMID: 7526801
Ref: Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis.
PMID: 7889467
Ref: Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors.
PMID: 8773262
Ref: Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors.
PMID: 8893333
Ref: Adhesion molecules involved in pleural dissemination of esophageal cancer cells.
PMID: 21594508
Ref: [Molecular diagnosis of gastrointestinal cancers].
PMID: 9474927
Ref: Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis.
PMID: 10037277
Ref: Tumor marker expression is predictive of survival in patients with esophageal cancer.
PMID: 11565671
Ref: Effects of body-resistance strengthening and tumor-suppressing granules on immune adhesion function of red blood cells and expression of metastasis protein CD44 in tumor cells of patients with esophageal carcinoma.
PMID: 17708612
Ref: Modern methods to predict costs for the treatment and management of head and neck cancer patients: examples of methods used in the current literature.
PMID: 18327029
Ref: Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation.
PMID: 19860666
Ref: Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.
PMID: 20463012
Ref: Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44.
PMID: 21731740
Ref: CD44 upregulation in E-cadherin-negative esophageal cancers results in cell invasion.
PMID: 22069487
Ref: Nucleostemin and TWIST as predictive markers for recurrence after neoadjuvant chemotherapy for esophageal carcinoma.
PMID: 22050045
Ref: Mesenchymal stem-like cells isolated from human esophageal carcinoma and adjacent non-cancerous tissues.
PMID: 23255916
Ref: HSP72 and gp96 in gastroenterological cancers.
PMID: 23266770
Ref: The usefulness of three-dimensional cell culture in induction of cancer stem cells from esophageal squamous cell carcinoma cell lines.
PMID: 23602898
Ref: Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markers.
PMID: 23684587
Ref: Evaluating stem and cancerous biomarkers in CD15+CD44+ KYSE30 cells.
PMID: 23797812
Ref: A new method for identifying stem-like cells in esophageal cancer cell lines.
PMID: 23983818
Ref: Physiological beta-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma.
PMID: 24073846
Ref: Growth, clonability, and radiation resistance of esophageal carcinoma-derived stem-like cells.
PMID: 24083764
Ref: XB130 promotes proliferation and invasion of gastric cancer cells.
PMID: 24387290
Ref: IGFBP3 promotes esophageal cancer growth by suppressing oxidative stress in hypoxic tumor microenvironment.
PMID: 24482736
Ref: Loss of CD44 and SOX2 expression is correlated with a poor prognosis in esophageal adenocarcinoma patients.
PMID: 24833101
Ref: Anti-CSC effects in human esophageal squamous cell carcinomas and Eca109/9706 cells induced by nanoliposomal quercetin alone or combined with CD 133 antiserum.
PMID: 25374189
Ref: MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.
PMID: 25375090
Ref: Peritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugs.
PMID: 25383653
Ref: [Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines].
PMID: 25430022
Ref: Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines.
PMID: 25561796
Ref: Mitochondrial SOD2 regulates epithelial-mesenchymal transition and cell populations defined by differential CD44 expression.
PMID: 25659582
Ref: CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy.
PMID: 26364884
Ref: ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma.
PMID: 26571024
Ref: Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
PMID: 27189061
Ref: Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
PMID: 27748881
Ref: The Prognostic Value of CD44 Expression in Epithelial-Mesenchymal Transition: Preliminary Data from Patients with Gastric and Esophageal Cancer.
PMID: 27815484
Ref: Tumor endothelial cells promote metastasis and cancer stem cell-like phenotype through elevated Epiregulin in esophageal cancer.
PMID: 27822417
Ref: Valproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma.
PMID: 27826618
Ref: MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44.
PMID: 29094237
Ref: TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.
PMID: 30134247